Abbreviations

Antiretroviral drug (ARV) abbreviations

3TC lamivudine

ABC abacavir

ATV atazanavir

BIC bictegravir

CAB cabotegravir

COBI cobicistat (used as booster=/c)

d4T stavudine

ddI didanosine

DOR doravirine

DRV darunavir

DTG dolutegravir

EFV efavirenz

EVG elvitegravir

ENF enfuvirtide (T20)

ETV etravirine

FI fusion inhibitor

FPV fosamprenavir

FTC emtricitabine

FTR fostemsavir

IDV indinavir

INSTI integrase strand transfer inhibitor

LEN lenacapavir 

LPV lopinavir

MVC maraviroc

NRTI nucleos(t)ide reverse transcriptase inhibitors 

NNRTI non-nucleoside reverse transcriptase inhibitors

NVP nevirapine

PI protease inhibitors

PI/b protease inhibitors pharmacologically boosted with cobicistat or ritonavir

PI/c protease inhibitor pharmacologically boosted with cobicistat

PI/r protease inhibitors pharmacologically boosted with ritonavir

RAL raltegravir

RPV rilpivirine

RTV ritonavir (used as booster=/r)

SQV saquinavir

TAF tenofovir alafenamide

TDF tenofovir disoproxil fumarate

TPV tipranavir

ZDV zidovudine

XTC 3TC or FTC

Other abbreviations

ACEi angiotensin converting enzyme inhibitor

AFP alpha-foetoprotein

ALP alkaline phosphatase

ALT alanine aminotransferase

aMDRD abbreviated modification of diet in renal disease formula

ARB angiotensin receptor blocker

ART antiretroviral therapy

AST aspartate aminotransferase

ASCVD atherosclerotic cardiovascular disease

B buprenorphine

bid twice daily

BMD bone mineral density

BMI body mass index

BP blood pressure

CABG coronary artery bypass grafting

CAPD continuous ambulatory peritoneal dialysis

CAD coronary artery disease

cART combination antiretroviral treatment

CBT cognitive behavioural therapy

CCB calcium channel blocker

CGA comprehensive geriatric assessment

CisW Cis-women

CKD chronic kidney disease

CKD-EPI CKD epidemiology collaboration formula

CMV Cytomegalovirus

CNS central nervous system

COPD chronic obstructive pulmonary disease

COVID-19 Coronavirus disease 2019

CSF cerebrospinal fluid

CTC computed tomography colonoscopy

CVD cardiovascular disease

CXR chest X-ray

DAA direct acting antiviral drug

DDI drug-drug interaction

DPP-4i dipeptidyl peptidase 4 inhibitor

DRESS drug rash with eosinophilia and systemic symptoms

DXA dual energy X-ray absorptiometry

ECG electrocardiogram

eGFR estimated glomerular filtration rate

ESLD end stage liver disease

FBC full blood count

FH familial hypercholesterolaemia

FIT faecal immunochemistry test

FRAX® fracture risk assessment tool

FRAT falls risk assessment tool

FS frailty scale

GAD-2 generalized anxiety disorder 2-item screening tool

GDR genotypic drug resistance test

GLP1RA glucagon like peptide 1 receptor agonist

GT genotype

HAV Hepatitis A virus

HAD HIV-associated dementia

HBV Hepatitis B virus

HCC hepatocellular carcinoma

HCV Hepatitis C virus

HDL-c HDL-cholesterol

HDV Hepatitis D virus

HEV Hepatitis E virus

HF heart failure

HIVAN HIV-associated nephropathy

HIV-VL HIV viral load (HIV-RNA)

HMOD hypertension-mediated organ disease

HPV Human papillomavirus

HRS hepatorenal syndrome

HSIL High-grade squamous intraepithelial lesion

HSR hypersensitivity reaction

HSV Herpes simplex virus

ICS Inhaled corticosteroid

IFG Impaired Fasting Glucose

IFN interferon

IGRA interferon-gamma release assay

IGT impaired glucose tolerance

IHD ischaemic heart disease

im intramuscular

IRIS immune reconstitution inflammatory syndrome

iv intravenous

IVDU intravenous drug use

LA long-acting

LABA long-acting β2-agonist

LAMA long-acting muscarinic antagonist

LDL-c LDL-cholesterol

LGV lymphogranuloma venereum

LOQ limit of quantification

MASH metabolic dysfunction-associated steatohepatitis

MASLD metabolic dysfunction-associated steatotic liver-disease

MDR-TB multidrug resistant TB

MDT multidisciplinary team

Mg magnesium

MND mild neurocognitive disorder

MRI magnetic resonance imaging

MSM men who have sex with men

MSW men who have sex with women

MTCT mother to child transmission

MT multitarget

sDNA stool DNA

MRI magnetic resonance imaging

MX methylxanthines

N norbuprenorphine

NSAID non-steroidal anti-inflammatory

NP neuropsychological

OIs opportunistic infections

OLTX orthotopic liver transplantation

PAP papanicolaou test

PCI percutaneous coronary intervention

PD4 phosphodiesterase 4 inhibitors

PEP post-exposure prophylaxis

PrEP pre-exposure prophylaxis

PEG-IFN pegylated-interferon

PHI primary HIV infection

po per oral

PPD purified protein derivative

PPI proton pump inhibitor

PRT proximal renal tubulopathy

PSA prostate specific antigen

PCSK9 proprotein convertase subtilisin/kexin type 9

PTH parathyroid hormone

PVC paediatric virtual clinic

qd once daily

qid four times daily

RAS resistance-associated substitutions

RBV ribavirin

RCT randomized controlled trial

RIG Rabies Immunoglobulin

SARS-CoV-2 Severe Acute Respiratory Syndrome Coronavirus-2

SABA short-acting β2-agonist

SAMA short-acting muscarinic antagonist

sc subcutaneous

SCORE systemic coronary risk estimation

SGLT-2i sodium/glucose co-transporter 2 inhibitor

SOT solid organ transplant

SPPB short physical performance battery

SSRI selective serotonin-reuptake inhibitor

STI sexually transmitted infection

SU sulfonylurea

SVR sustained virological response

TBS trabecular bone score

TC total cholesterol

TDM therapeutic drug monitoring

TG triglycerides

TIA transient ischaemic attack

tid three times daily

TMP-SMX trimethoprim-sulfamethoxazole

TW transgender women

TZD thiazolidinediones

UA/C urine albumin/creatinine ratio

UP/C urine protein/creatinine ratio

US ultrasound

VL viral load (HIV-RNA)

VZV varicella-zoster virus

WB western blot

XDR-TB extensively drug-resistant TB

Zn zinc